Human Plasma-Derived, Nanofiltered, C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting from C1-Inhibitor Deficiency.
about
Human Plasma-Derived, Nanofiltered, C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting from C1-Inhibitor Deficiency.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 May 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human Plasma-Derived, Nanofilt ...... from C1-Inhibitor Deficiency.
@en
Human Plasma-Derived, Nanofilt ...... from C1-Inhibitor Deficiency.
@nl
type
label
Human Plasma-Derived, Nanofilt ...... from C1-Inhibitor Deficiency.
@en
Human Plasma-Derived, Nanofilt ...... from C1-Inhibitor Deficiency.
@nl
prefLabel
Human Plasma-Derived, Nanofilt ...... from C1-Inhibitor Deficiency.
@en
Human Plasma-Derived, Nanofilt ...... from C1-Inhibitor Deficiency.
@nl
P2860
P1433
P1476
Human Plasma-Derived, Nanofilt ...... from C1-Inhibitor Deficiency.
@en
P2093
Henriette Farkas
Lilian Varga
P2860
P2888
P356
10.1007/S13554-012-0002-5
P577
2012-05-09T00:00:00Z